Myeloproliferative Neoplasms Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Myeloproliferative neoplasms program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Myeloproliferative Neoplasms Program Today - Breaking & Trending Today

Asciminib Elicits Safe and Durable Responses in Previously Treated CML

Treatment with asciminib elicited greater efficacy and had a more tolerable safety profile compared with bosutinib for patients chronic myeloid leukemia in chronic phase following treatment with 2 or more TKIs. ....

Michael Mauro , Memorial Sloan Kettering Cancer Center , Myeloproliferative Neoplasms Program , Ash Annual Meeting And Exposition ,

MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study Seite 1

11.12.2023 - MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-naïve . Seite 1 ....

Raajitk Rampal , Myeloproliferative Neoplasms Program , Memorial Sloan Kettering Cancer Center , Hematologic Malignancies , Memorial Sloan , Kettering Cancer , Morphosys Aktie ,